Membranoproliferative glomerulonephritis and mixed cryoglobulinemia after hepatitis C virus infection secondary to glomerular NS3 viral antigen deposits

American Journal of Nephrology

Volumn 35, Issue 2, 2012, Pages 134-140

  Bataille, Stanislas ^a   Kaplanski, Gilles ^b   Boucraut, José ^a   Halfon, Philippe ^d   Camus, Claire ^d   Daniel, Laurent ^c   Burtey, Stéphane ^a   Berland, Yvon ^a   Dussol, Bertrand ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HÔpital La Conception   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d Laboratoire Alphabio   (France)

Author keywords

B lymphocyte; Cryoglobulinemia; HCV NS3 antigen; Hepatitis C virus; Membranoproliferative glomerulonephritis

Indexed keywords

CRYOGLOBULIN; INTERFERON; NONSTRUCTURAL PROTEIN 3; RIBAVIRIN; RITUXIMAB; VIRUS ANTIGEN; VIRUS RNA;

ADULT; ANAMNESIS; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; BONE MARROW CELL; CASE REPORT; CELL PROLIFERATION; CLINICAL EXAMINATION; CRYOGLOBULINEMIA; CRYOPRECIPITATE; FOLLOW UP; GLOMERULUS; HEMATOPOIETIC CELL; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY DISEASE; LABORATORY TEST; LIVER BIOPSY; LYMPHOCYTE TYPING; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MICROSCOPY; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIODENSITOMETRY; REMISSION;

ADULT; ANTIGENS, VIRAL; B-LYMPHOCYTES; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEPACIVIRUS; HEPATITIS C; HUMANS; LYMPHOCYTOSIS; MALE; MIDDLE AGED; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84855798774     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000335375     Document Type: Article

References (33)

1. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, et al: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-470. (Pubitemid 23056436)
2. Cacoub P, Musset L: Mixed cryoglobulinemia. Rev Prat 2000; 50: 276-280.
3. Kamar N, Izopet J, Alric L, et al: Hepatitis C virus-related kidney disease: An overview. Clin Nephrol 2008; 69: 149-160. (Pubitemid 351351061)
4. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC, et al: Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-1300. (Pubitemid 24129247)
5. El-Serag HB, Hampel H, Yeh C, Rabeneck L: Extra hepatic manifestations of hepatitis C among United States Male Veterans. Hepatology 2002; 36: 1439-1445. (Pubitemid 35403535)
6. Licht C, Schlötzer-Schrehardt U, Kirschfink M, Zipfel PF, Hoppe B: MPGN II -genetically determined by defective complement regulation? Pediatr Nephrol 2007; 22: 2-9. (Pubitemid 46138352)
7. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M: Biological and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974; 57: 775-778.
8. Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P: Relapse of hepatitis C virus associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum 2008; 58: 604-611. (Pubitemid 351294898)
9. Harle JR, Disdier P, Durand JM, Alessi MC, Boucraut J, Rouseau J, Kaplanski G, Weiller PJ: Mixed cryoglobulinemia in hepatitis C virus infection. 10 cases. Presse Med 1991; 20: 1233.
10. Castillo I, Pardo M, Bartolomé J, Ortiz-Movilla N, Rodríguez-Iñigo E, de Lucas S, Salas C, Jiménez-Heffernan JA, Pérez-Mota A, Graus J, López-Alcorocho JM, Carreño V: Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004; 189: 7-14. (Pubitemid 38122323)
11. Castillo I, Rodriguez-Inigo E, Bartolomé J, de Lucas S, Ortíz-Movilla N, López-Alcorocho JM, Pardo M, Carreño V: Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 2005; 54: 682-685. (Pubitemid 40559255)
12. Pham TN, Michalak TI: Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol 2008; 14: 2789-2793.
13. Halfon P, Martinot-Peignoux M, Cacoub P: The myth of occult hepatitis C infection. Hepatology 2009; 50: 1675.
14. Giannini C, Petrarca A, Monti M, Arena U, Caini P, Solazzo V, Gragnani L, Milani S, Laffi G, Zignego AL: Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia. Blood 2008; 111: 2943-2945.
15. Levine JW, Gota C, Fessier BJ, Calabrese LH, Cooper SM: Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol 2005; 32: 1164-1167. (Pubitemid 40828106)
16. Halfon P, Bourlière M, Ouzan D, Sène D, Saadoun D, Khiri H, Pénaranda G, Martineau A, Oulès V, Cacoub P: Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay. J Clin Microbiol 2008; 46: 2106-2108. (Pubitemid 351831855)
17. Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
18. Welker MW, Zeuzem S: Occult hepatitis C: How convincing are the current data? Hepatology 2009; 49: 665-675.
19. Cao Y, Zhang Y, Wang S, Zou W: Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis. Nephrol Dial Transplant 2009; 24: 2745-2751.
20. Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F: Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol 2005; 140: 498-506. (Pubitemid 40813960)
21. Nepomnyashchikh GI, Aidagulova SV, Nepomnyashchikh DL, Tolokonskaya NP, Karavaeva YY, Sakharova EG, Mezentseva GA, Batemirova EV: Immunohistochemichal, molecular, and pathomorphological study of liver biopsy specimens during chronic hepatitis C. Bull Exp Biol Med 2002; 134: 307-311. (Pubitemid 36221387)
22. Sène D, Limal N, Ghillani-Dalbin P, Saadoun D, Piette JC, Cacoub P: Hepatitis C virus-associated B-cell proliferation -the role of serum B lymphocyte stimulator (BLys/BAFF). Rheumatology 2007; 46: 65-69. (Pubitemid 44932786)
23. Landau DA, Saadoun D, Calabrese LH, Cacoub P: The pathophysiology of HCV induced B-cell clonal disorders. Autoimmun Rev 2007; 6: 581-587. (Pubitemid 47374619)
24. Nieters A, Kallinowski B, Brennan P, Ott M, Maynadié M, Benavente Y, Foretova L, Cocco PL, Staines A, Vornanen M, Whitby D, Boffetta P, Becker N, De Sanjosé S: Hepatitis C and risk of lymphoma: Results of the European multicenter case-control study EPILYMPH. Gastroenterology 2006; 131: 1879-1886. (Pubitemid 44958516)
25. Cocco PL, Piras G, Monne M, Uras A, Gabbas A, Ennas MG, Palmas A, Murineddu M, Collu S, Melis M, Rais M, Todde P, Cabras MG, Angelucci E, Massarelli G, Nieters A: Risk of malignant lymphoma following viral hepatitis infection. Int J Hematol 2008; 87: 474-483.
26. Schöllkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Panum I, Vinner L, Chang ET, Glimelius B, Porwit A, Sundström C, Hansen M, Adami HO, Melbye M: Hepatitis C infection and risk of malignant lymphoma. Int J Cancer 2008; 122: 1885-1890. (Pubitemid 351413439)
27. De Re V, De Vita S, Marzotto A, Rupolo M, Gloghini A, Pivetta B, Gasparotto D, Carbone A, Boiocchi M: Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggest that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000; 96: 3578-3584.
28. Ferri S, Dal Pero F, Bortoletto G, Bianchi FB, Lenzi M, Alberti A, Gerotto M: Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia. J Viral Hepat 2006; 13: 166-176.
29. Zehender G, De Maddalena C, Bernini F, Ebranati E, Monti G, Pioltelli P, Galli M: Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome. J Virol 2005; 79: 9145-9156. (Pubitemid 40934826)
30. Maruyama S, Hirayama C, Horie Y, Yorozu K, Maeda K, Inoue M, Fujii Y, Umeki K, Koda M: Serum immunoglobulins in patients with chronic hepatitis C: A surrogate marker of disease severity and treatment outcome. Hepatogastroenterology 2007; 54: 493-498. (Pubitemid 46724714)
31. Carbone A, Manconi R, Poletti A, Tirelli U, De Paoli P, Santini G, Diodato S, Manconi PE, Grigoletto E, Santi L, et al: Lymph node immunohistology in intravenous drug abusers with persistent generalized lymphadenopathy. Arch Pathol Lab Med 1985; 109: 1007-1012. (Pubitemid 16231414)
32. Haydey RP, Patarroyo de Rojas M, Gigli I: A newly described control mechanism of complement activation in patients with mixed cryoglobulinemia (cryoglobulins and complement). J Invest Dermatol 1980; 74: 328-332. (Pubitemid 10034231)
33. Saadoun D, Sadallah S, Trendelenburg M, Limal N, Sene D, Piette JC, Schifferli JA, Cacoub P: Anti-C1q antibodies in hepatitis C virus infection. Clin Exp Immunol 2006; 145: 308-312. (Pubitemid 44060122)